Do you need guidance for negotiating and drafting a non-jurisdictional settlement agreement and release of claims for a single-plaintiff employment dispute? Use our newly published playbook, Settlement...
In May 2025, the SEC’s Division of Trading and Markets, along with a separate statement by SEC Commissioner Peirce, released FAQs that provide long-awaited clarity on the regulatory treatment of...
Both the House and Senate versions of the One Big Beautiful Bill Act (OBBBA), passed by the House on May 22, 2025, and the Senate on July 1, 2025, phase out tax credits for wind, solar, and electric vehicle...
Playbooks help attorneys review, draft, and negotiate contracts efficiently and consistently by comparing favored contract language with fallback language and providing drafting guidance and negotiation...
In the intricate world of M&A transactions, tax considerations often determine deal viability, structure optimization, and ultimate value creation. Navigate the complex landscape where strategic tax...
* The views expressed in externally authored materials linked or published on this site do not necessarily reflect the views of LexisNexis Legal & Professional.
FTC Chair Lina Khan told a conference of the American Medical Association on February 14, 2024, that the healthcare market is under the microscope in the Commission’s push for greater competition across the economy. Recent efforts by the FTC in this space include requesting public comment on how powerful “middlemen” in the generic drug market may contribute to shortages of these drugs. The agency also announced a March 5 virtual workshop to examine the role of private equity’s investment in healthcare markets. Additionally, the FTC issued a recent comment supporting the government’s right to “march in” to invalidate a patent if the patent holder is charging an excessive price on a patented drug developed with taxpayer-funded research.
The Antitrust Agency Developments Tracker covers these developments and other FTC and DOJ non-case-related efforts, policy statements, and goings-on at the agencies.
READ NOW »
Related Content
Practical Guidance Updates Featuring the latest updates from your Practical Guidance account.
PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB
Experience results today with practical guidance, legal research, and data-driven insights—all in one place.Experience Lexis+